FDA Clears Halt Medical’s Acessa™ Uterine Fibroid Treatment

Halt Medical, Inc. announced today at the opening session of the AAGL Global Congress on Minimally Invasive Gynecology that the FDA has cleared Acessa™, a revolutionary new medical technology for treating millions of women suffering from uterine fibroids.



Acessa™ by Halt Medical receives FDA approval for treating uterine fibroids (via PR Newswire)

LAS VEGAS, Nov. 6, 2012 /PRNewswire/ — Halt Medical, Inc. announced today at the opening session of the AAGL Global Congress on Minimally Invasive Gynecology that the FDA has cleared Acessa™, a revolutionary new medical technology for treating millions of women suffering from uterine fibroids.  “…



published: November 7, 2012 in: Approval/Clearance, Gynaecology/Obstetrics

Most read

Latest

^